Philip Morris International (PMI) experienced a 5.6% jump in share prices after the FDA issued regulatory guidance favoring the commercialization of its products like ZYN Ultra and IQOS in the U.S. The company reported strong growth in its smoke-free segment, exceeding expectations in its first-quarter 2026 earnings, contributing to a 12.5% rise in shares since the start of the year. With a robust market cap of $291.3 billion and best-in-class margins, PMI is well-positioned in the evolving tobacco landscape under Altria's ownership.
“Altria, R.J. Reynolds Tobacco, Lorillard y Philip Morris USA · han intencionalmente diseñado · los cigarrillos para hacerlos más adictivos”
“Philip Morris USA · saw retail share growth of · two point four share points · in the discount segment”
“total Philip Morris USA retail share · grew · 0.1 share point sequentially · and 0.4 share points versus a year ago”
“Philip Morris International Inc · had · 8.96% in the portfolio · first quarter of 2026”
“Philip Morris International · is a company in · Consumer Staples”
“Philip Morris International · is a company in · Global”
“Altria · is the parent company of · Philip Morris USA”
“Altria · emerged from · Philip Morris USA”
“Altria · was created because · Philip Morris wished to emphasize that its business portfolio · more than Philip Morris USA and Philip Morris International”
“A United States court in 2006 · found that Philip Morris · disputed scientific findings linking smoking and disease knowing their assertions were false”
“Philip Morris · had its headquarters in · Midtown Manhattan, New York City · prior to being based in Virginia”
“Philip Morris · moved its headquarters to · Virginia · in 2003”
